Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-23T21:38:37.460Z Has data issue: false hasContentIssue false

Modified Narcosis, ECT and Antidepressant Drugs: A Review of Technique and Immediate Outcome

Published online by Cambridge University Press:  29 January 2018

C. J. S. Walter*
Affiliation:
Department of Psychological Medicine, St. Thomas' Hospital, London, S.E.1
Nita Mitchell-Heggs
Affiliation:
Department of Psychological Medicine, St. Thomas' Hospital, London, S.E.1
William Sargant
Affiliation:
Department of Psychological Medicine, St. Thomas' Hospital, London, S.E.1
*
Now Consultant Psychiatrist, Princess Alexandra Hospital, Harlow; Herts and Essex General Hospital, Bishop's Stortford; and Severalls Hospital, Colchester

Extract

The renewed use of modified forms of narcosis, generally given together with ECT and antidepressant drugs, arose from a series of observations made during attempts to treat a group of chronically tense patients. These patients, the majority of whom had been diagnosed as ‘chronic tension states', had been referred to the Department of Psychological Medicine at St. Thomas' Hospital for assessment regarding their suitability for modified leucotomy. Birley (1964), in a follow-up study of previous patients with ‘tension states' treated by leucotomy at St. Thomas' Hospital, had found that many developed clear-cut attacks of depression following the operation. This suggested to one of us (W.S.) that such ‘tension states' might have been masked depressive illnesses, in whom the underlying diagnosis had been missed. Consequently it was decided that in the future such patients should be treated with suitably long courses of ECT, together with one or both groups of antidepressant drugs, before any question of recommending leucotomy arose. As a result, a considerable number of these patients were greatly improved and no longer required a leucotomy. Others, however, became more tense and distressed during treatment with ECT and drugs; modified narcosis, therefore, was given in addition, to allow the full course of ECT to be completed. It was then that another of us (C.W.) observed that patients who were treated with combined narcosis, ECT and antidepressants appeared to respond more favourably, and were much less upset by the treatment, than those receiving ECT and antidepressants alone. In a preliminary report published in 1966, Sargant, Walter and Wright described a group of 73 patients with ‘chronic tension states', of whom 67 per cent had improved markedly with further treatment of their underlying depression. It was noted that 15 of the 37 patients treated with ECT and antidepressants alone still required a leucotomy, while in the group treated with modified narcosis in addition to ECT and antidepressants the operation was needed in only 3 of the 36 patients. It appeared, therefore, that the addition of narcosis to drugs and ECT greatly improved the recovery rate.

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1972 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Ackner, B., Harris, A., and Oldham, A. J. (1957). ‘Insulin treatment of schizophrenia: a controlled study.’ Lancet, i, 607–11.Google Scholar
2. Birley, J. L. T. (1964). ‘Modified frontal leucotomy: a review of 106 cases.’ British Journal of Psychiatry, 110, 211–21.Google Scholar
3. Clapp, J. S., and Loomis, E. A. (1950). ‘Continuous sleep treatment.’ American Journal of Psychiatry, 106, 821–29.Google ScholarPubMed
4. Clouston, T. S. (1883). Clinical Lectures on Mental Diseases. London: J. and A. Churchill.Google Scholar
5. Ey, H., and Faure, H. (1957). ‘Sleep therapy and the use of chlorpromazine.’ International Record of Medicine, 170, 110.Google ScholarPubMed
6. Gander, D. R. (1965). ‘Treatment of depressive illnesses with combined antidepressants.’ Lancet, ii, 107–9.Google Scholar
7. Griesinger, W. (1861). Mental Pathology and Therapeutics. (English Transl. 1867. London: New Sydenham Society).Google Scholar
8. Hammer, W., Idestrom, C. M., and Sjöqvist, F. (1967). ‘Chemical control of antidepressant drug therapy.’ Excerpta Medica (Amsterdam). International Congress Series No. 122, 301–10.Google Scholar
9. Kelly, D. H. W., and Walter, C. J. S. (1969). ‘A clinical and physiological relationship between anxiety and depression.’ British Journal of Psychiatry, 115, 401–6.Google Scholar
10. Kläsi, J. (1921). ‘Uber Somnifen, eine medikamentose Therapie schizophrener Aufregungszustande.’ Schweizer Archiv für Neurologic und Psychiatrie, 8, 131–4.Google Scholar
11. Kläsi, J. (1922). ‘Über die therapeutische Anwendung der “Dauernarkose” mittels Somnifens bei Schizophrenen.’ Zeitschrift für die gesamte Neurologie und Psychiatrie, 74, 557–92.Google Scholar
12. Liébault, A. A. (1866). Le Sommeil Provoqué et les États Analogues. Paris: Doin et Cie.Google Scholar
13. Möller, M. (1925). ‘Die Dauernarkose mit Somnifen in der Psychiatrie.’ Zeitschrift für die gesamte Neurologie und Psychiatrie, 96, 653–82.Google Scholar
14. McLeod, N. (1900). ‘The bromide sleep: A new departure in the treatment of acute mania.’ British Medical Journal, 1, 134–6.Google Scholar
15. Palmer, H. A. (1937). ‘The value of continuous narcosis in the treatment of mental disorder.’ Journal of Mental Science, 83, 636–78.Google Scholar
16. Palmer, H. D., and Paine, A. L. (1932). ‘Prolonged narcosis as therapy in the psychoses.’ American Journal of Psychiatry, 12, 143–64.Google Scholar
17. Sargant, W., and Slater, E. (1944 and 1963). An Introduction to Physical Methods of Treatment in Psychiatry. Edinburgh: Livingstone Ltd.Google Scholar
18. Sargant, W. Walter, C. J. S., and Wright, N. (1966). ‘New treatment of some chronic tension states.’ British Medical Journal, i, 322–4.Google Scholar
19. Serejski, M. J., and Feldmann, E. S. (1937). ‘Anwendung der Dauernarkose in der Psychiatrie.’ Zeitschrift für die gesamte Neurologie und Psychiatrie, 157, 246–76.Google Scholar
20. Walter, C. J. S. (1971). ‘Clinical significance of plasma imipramine levels.’ Proceedings of the Royal Society of Medicine, 64, 282–5.Google Scholar
21. Williams, R. L., and Webb, W. B. (1966). Sleep Therapy. Springfield, Illinois: Thomas and Co.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.